Can a proven cancer drug be reimagined to fight brain tumors in kids? | Breakthroughs Can't Wait
As an ACS-IMPACT Research Scholar at the University of Maryland, Baltimore, Gabrielle Olibris spent her summer in the lab of Aditi Banerjee, PhD, targeting medulloblastoma, a pediatric brain cancer, with a novel therapeutic compound called BNPP-433.3 Beta.BNPP-433.3 Beta shows strong potential, she said, explaining, “This is already patented, so it’s a drug that’s already being used to treat prostate cancer.”By exploring a new use for an existing cancer drug, Olibris hopes to help advance research that could lead to safer, more effective treatments for children.#breakthroughscantwaitumb #cancerresearch
More from Youtube
- 1:09Pain Management in Dementia: Finding the Root CauseWhen dementia takes away the ability to communicate pain, how can we help patients live more comfortably?Research led by University of Maryland School of Nursing professor Barbara Resnick, PhD, RN, CRNP, FAAN, FAANP, focuses on uncovering the root causes of discomfort, using advanced tools to assess and treat pain effectively in older adults. This work, supported by the National Institute on Aging, is part of our commitment to improving quality of life for people with dementia.#BreakthroughsCantWaitUMB #DementiaCare #PainManagement #AgingResearch #ElderCare #BrainHealth #DementiaAwareness #QualityOfLife
- 0:45Spotting Pain in Dementia Patients—Even When Words Are Gone | Breakthroughs Can’t WaitWhen dementia takes away a person’s ability to speak, pain often goes unnoticed and untreated.University of Maryland, Baltimore research aims to change that. By developing new methods to detect discomfort in non-verbal patients, we can improve quality of life and provide more compassionate care.Supported by the National Institute on Aging. #BreakthroughsCantWaitUMB #DementiaCare #PainManagement #Alzheimers #AgingResearch #ElderCare #BrainHealth #HealthcareInnovation
